Invesaro

Stocks GROW Financial statements

Financial statements

U S GLOBAL INVESTORS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data U S GLOBAL INVESTORS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue6.766.263.464.4821.724.715.11110.814.4
Gross profit-0.533.59
General and administrative3.493.872.923.665.76.916.126.065.85.34
Operating expenses7.648.556.226.8813.513.611.511.511.410.9
Operating income-0.87-2.29-2.76-2.48.1711.13.53-0.48-2.99-0.6
Interest expense000
Interest income0.820.890.320.170.461.951.82.412.191.47
Other non-operating income0.353.17-1.51-2.2429.3-6.150.562.42.724.49
Pre-tax income-0.530.89-4.27-4.6437.44.974.081.92-0.263.88
Income tax0.020.2-0.98-0.185.481.530.930.580.070.83
Income from continuing operations-0.51
Net income to minority interests-0.030.04-0.05-0.120
Net income-0.510.65-3.39-4.68323.443.151.33-0.333.06
EBITDA-0.62-2.05-2.54-2.28.5410.73.28-0.62-3.1-0.59
EPS, basic-0.030.04-0.20-0.291.950.230.220.09-0.030.24
EPS, diluted-0.030.04-0.20-0.291.950.230.220.09-0.030.24
Shares, basic (weighted)16.516.516.516.416.41514.614.213.312.7
Shares, diluted (weighted)16.516.516.516.416.41514.614.213.312.7
Dividend per share0.010.010.01

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents3.966.361.471.9414.422.325.427.424.624.3
Short-term investments8.188.026.326.3212.111.69.649.698.87
Receivables00.750
Other current assets0.320.330.290.290.350.40.510.50.550.53
Total current assets17.517.113.110.526.83840.440.339.137.6
Property, plant and equipment2.211.971.711.511.381.371.141.151.11.12
Lease right-of-use assets00.090.040
Long-term investments7.097.175.141710.61.561.452.52.87
Other non-current assets0.080.070.060.090.10.220.220.20.20.26
Total assets25.528.923.718.862.358.455.75248.148
Accounts payable0.120.20.030.030.10.070.140.010.010
Accrued liabilities0.390.650.310.361.561.861.170.610.470.45
Total current liabilities1.171.771.432.015.154.132.942.161.871.91
Long-term debt00.080.08
Lease liabilities00.040
Total liabilities1.172.871.572.057.954.583.652.962.862.9
Total debt000
Paid-in capital15.615.715.615.615.716.416.416.416.616.6
Retained earnings9.329.517.762.6333.835.937.637.535.937.9
Treasury stock-1.76-1.88-1.89-1.88-2.17-2.6-3.74-5.88-7.78-9.69
Other comprehensive income0.261.86-0.21-06.593.621.350.580.10
Shareholders' equity23.925.521.716.854.353.6524945.245.1
Minority interests0.480.520.470
Total equity24.426.122.216.854.353.6524945.245.1
Total liabilities and equity25.528.923.718.862.358.455.75248.148

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-0.540.69-3.44-4.8323.443.151.33-0.333.06
Depreciation and amortization0.250.240.210.20.37-0.42-0.25-0.14-0.120.01
Stock-based compensation00000.040.73000.120.01
Deferred income tax00.05-0.97-0.141.06-2.89-0.440.340.71-0.17
Change in payables-0.140.62-0.460.663.43-0.69-1.19-0.8-0.240.04
Cash from operations0.69-0.03-1.08-1.954.7710.52.910.99-0.820.74
Capital expenditures0000-0.07-0.22-0.01-0.21-0.01-0.06
Purchases of investments-2.42-1.590-9.1500
Cash from investing-0.163.06-1.732.548.65-1.022.674.421.062.12
Stock issued0.010.01000.010.050.060.070.070.07
Share buybacks-0.11-0.14-0.02-0.11-0.31-0.45-1.2-2.17-1.97-1.97
Dividends paid-0.46-0.46-0.45-0.45-0.64-1.24-1.33-1.28-1.21-1.14
Cash from financing-0.56-0.59-0.47-0.12-0.94-1.64-2.5-3.41-3.08-3.09
Exchange rate effect-0-0.030
Net change in cash-0.042.41-3.390.4712.57.883.092-2.85-0.22
Free cash flow0.69-0.03-1.08-1.954.6910.32.90.78-0.830.68
Interest paid00000.01
Income taxes paid0.020.010.1204.74.141.490.250.060.05

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $2.98 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin25.0%Gross profit / revenue.
Operating margin-4.2%Operating income / revenue.
EBITDA margin-4.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin27.0%Pre-tax income / revenue.
Net margin21.2%Net income / revenue.
FCF margin4.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin5.2%Cash from operations / revenue.
Effective tax rate21.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)6.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)6.4%Net income / average total assets.
Return on invested capital (ROIC)-2.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.4%Capital expenditures / revenue.
D&A / revenue0.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y32.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-1.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-7.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y-1.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-37.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y2.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-34.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y-36.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-31.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y-38.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-32.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-0.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-4.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-3.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-0.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-4.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-5.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-4.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-5.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio19.7xCurrent assets / current liabilities.
Quick ratio17.4x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio17.4x(Cash + short-term investments) / current liabilities.
Liabilities / assets6.0%Total liabilities / total assets.
Working capital$35.7MCurrent assets - current liabilities.
Tangible book value$45.1MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.30xRevenue / average total assets.
Fixed asset turnover13.0xRevenue / average property, plant and equipment.
Receivables turnover38.4xRevenue / average receivables.
Days sales outstanding10 days365 x average receivables / revenue.
FCF conversion22.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow8.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.24Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.24Net income per basic share, as reported (split-adjusted).
Revenue per share$1.13Revenue / diluted weighted shares.
FCF per share$0.05Free cash flow / diluted weighted shares.
Operating cash flow per share$0.06Cash from operations / diluted weighted shares.
Book value per share$3.56Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$3.56Tangible book value / shares outstanding.
Cash per share$2.62(Cash + short-term investments) / shares outstanding.
Dividend per share$0.01Dividend declared per common share (paid, when declared is not tagged).
Payout ratio37.3%Dividends paid / net income, when net income is positive.
Dividends / FCF167.3%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF289.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$37.0MShare price x shares outstanding.
Enterprise value$3.8MMarket cap + total debt - cash - short-term investments.
P/E12.1xMarket cap / net income. Only when net income is positive.
P/S2.57xMarket cap / revenue.
P/B0.82xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.82xMarket cap / tangible book value, when positive.
P/FCF54.2xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF49.8xMarket cap / cash from operations, when positive.
EV/Sales0.26xEnterprise value / revenue.
EV/FCF5.52xEnterprise value / free cash flow, when both are positive.
FCF yield1.8%Free cash flow / market cap.
Earnings yield8.3%Net income / market cap (the inverse of P/E).
Dividend yield3.1%Dividends paid over the period / market cap.
Shareholder yield8.4%(Dividends paid + share buybacks) / market cap.
PEG4.11xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was U S GLOBAL INVESTORS INC's revenue in fiscal 2026?

U S GLOBAL INVESTORS INC reported revenue of $14.4M for fiscal 2026, 32.8% higher than the year before.

Was U S GLOBAL INVESTORS INC profitable in fiscal 2026?

Yes. Net income was $3.1M, a net margin of 21.2%.

How much free cash flow did U S GLOBAL INVESTORS INC generate in fiscal 2026?

Cash from operations of $742.0K minus capital expenditures of $60.0K left free cash flow of $682.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to U S GLOBAL INVESTORS INC